|
R.E.W.
Hancock: Appointments, Consulting and other service Appointments (Academic and Honourary) §
2008-. Citizenship Judge (Presiding Officer at Canadian Citizenship
ceremonies) § 2003-10 Centre for Drug Research and Development, Steering Committee, Joint Development Committee. §
2004-05, Centre for Drug Research and Development,
Chair, Drug Evaluation and Selection Committee. §
2005-10 Co-Director,
Pathogenomics of Innate Immunity Program (Genome §
2002-05 Co-Director,
Functional Pathogenomics of Mucosal Immunity Program. §
2002 Fellow, § 2001-02 President and Founder, Inimex Pharmaceuticals Inc
§
2001 Officer of the Order of § 2001-14 Canada Research Chair in Microbiology/Genomics and Health cluster at UBC. § 2000-02 Member of the Executive Group to coordinate Canadian Food Microbiology activities.
§
2000 § 2000 MRC CIHR Institute Simulation committee. § 1998-02 Chair, PseudoCAP (Pseudomonas aeruginosa community genome annotation project) § 1997- Director, UBC Centre for Microbial Diseases and Immunity Research § 1994 WHO Committee on Antimicrobial Resistance and Surveillance § 1989-96 Founding Scientific Director, Canadian Bacterial Diseases Network § 1987-93 Medical Scientific Advisory Cte, Canadian Cystic Fibrosis Foundation, Chair, 90-93.
§
1986- Professor, Microbiology,
§
1985-86 President,
§
1984-85 Vice President,
§
1983- Associate Member, Pediatrics,
§
1983-86 Associate Professor with tenure, Microbiology,
§
1978-83 Assistant Professor, Microbiology,
§
1977-78 Research Bacteriologist I,
§ 1975-77 Alexander von Humboldt Stipendiat, University Tubingen, Germany Memberships on scholarly societies § Member of American Society for Microbiology, 1977-.
§
Member of Infectious Diseases Society of § Member of Canadian Society of Microbiologists 1985-89; 1991-. §
Member of Association for the Prudent Use of Antibiotics
1985-. §
Member of the Canadian Society for Systems Biology 2008-. Memberships on scholarly committees § President, Northwest Branch, American Society for Microbiology, 1985-86. § Canadian Cystic Fibrosis Foundation, Medical/Scientific Advisory Cte Exec. 1988-93. § Vaccine Evaluation Centre, Advisory Board, 1988-92. § MRC Grants committee for Microbiology and Infectious Diseases 1982-84. § Canadian Cystic Fibrosis Foundation Grants Committee, 1987-90.
§
Member of § Canadian Cystic Fibrosis Foundation, MSAC Chair, 1990-93. § Canadian Society of Microbiologists, CSM Awards Committee, 1994-7; Chair, 1997.
§
Fellowship Review Committee, Life Sciences Div., Academy
III, Royal Society of § UBC CIHR transition committee. 1999- 2000. § CIHR Standing Committee in BC. 2000-. § Canadian Institutes of Health Research Institute Simulation Committee, Feb - Mar, 2000. § Scientific Advisory Committee, Michael Smith Foundation for Health Research, Founding member, 2000-3. § Vancouver Hospitals HSC Microbial Pathogenesis Review Committee, 2000-2.
§
§ BC Biotech Awards Committee 2001-4.
§
Health § Mike Smith Foundation for Medical Research – New Opportunities Task Force, 2004. §
Consultant reviewer, CIHR Microbiology & Infectious
Diseases Grants Review Cte, 2005, 2006, 2007.
§
Promega Biotechnology Research Award Selection Cte, §
Advisory Board, Faculty of Sciences, §
Coordinator and White paper main author, Canada
California Cooperation Network, 2006, 2008. §
International Neuropeptide Society: President,
Bacterial/Antibiotic Peptide Group 2007-. §
Advisory Board, Webster Centre for Molecular Research in
Infectious Diseases, U. Otago, 2007-. §
Advisory Board, Universities Allied for Essential Medicines,
UBC, 2007-. §
Presented (with Dr. Lorne Tyrell) White paper on
Infection and Immunity to Genome §
Nominations Committee for the Sanofi-AventisAward, July
2009-2012. §
Consultant reviewer, CIHR Pharmacology & Toxicology
Grants Review Panel, 2009. §
Consultant reviewer, CIHR Microbiology and Infectious
Diseases Grants Review Panel, 2009. §
Steering Committee (and co-founder), UBC Neglected
Global Diseases Initiative, 2009-. § Steering Committee, Gates Foundation Grand Challenge program. “Linking innate and specific immunity to
develop single-dose vaccines for neonates”.
2008-11. §
Nominations Committee for the Sanofi-Aventis Award,
2009-2012. § Advisor, Accessible Science Initiative (student initiative to provide science education in developing
countries), 2009-. §
Reviewer for Canadian Foundation for Innovation, 2009-. Editorships § Editorial Board, Journal of Bacteriology, 1982-90. § Editorial Board, Infection and Immunity, 1986-89. § Editorial Board, Antimicrobial Agents and Chemotherapy, 1987-07. § Associate Editor, Canadian Journal of Microbiology 1988-90. § Editorial Board, Current Biology, 1997 - § International Advisory Board, Current Microbiology and Infection, 1996 - §
Current Opinion in Microbiology, Antimicrobials issue
editor, October 1998. §
Drug Resistance Updates, 1997- §
Editorial Board, The Infectious Diseases Review, 1998- §
Editorial Board, Current Opinion in Anti-infective
Drugs, 1998- §
Editorial Board, Peptides, 2005- §
Editorial Board, Microbial Drug Resistance 2009- §
Editorial Board, Annual Reviews in Antimicrobial
Therapeutics 2009- External examiner
§
Ken Jarrell,
§
X.Wa Wong,
§
Dmitrii Rodionov,
§
John McCormick, §
Ellen James, §
Mary Burtnik, §
Hilde Ulvatne, §
Ørjan Samuelsen, University §
Sarah Marjorie Sanowar, §
Erin van Schaik, §
Li Peng, §
Nicole van der Weerden, La Trobe University, 2007. §
Kara M Swanson, University Otago, 2007. §
Donna S. Easton, University
Canberra, 2008 Consultant § Centocor Corporation, Philadelphia, Pennsylvania, 1983-86. § Bristol-Myers-Squibb, Ltd., Syracuse, New York, 1984-91. § Oncogen, Seattle, WA, 1988-91. § Genta Inc., San Diego, 1993-95 § Cubist Pharmaceuticals, 1994. § Micrologix Biotech Inc, Vancouver, BC, 1994-98.
§
Affymax Inc., Santa Clara, CA.,
1995.
§
Gruppo Lepetit (Marion Merrill
Dow), Geranzano, Italy, 1995.
§
Vicuron (formerly Versicor), San
Francisco, CA, 1996-
§
Department of National Defence,
§
§ Canadian Inovatech, Abbottsford, BC, 1997-2000.
§
Pathogenesis,
§
Becton Dickinson,
§
Geltex,
§
Synphar Inc, § National Research Council, 1999-2000. § Smart & Biggar/Astra, 2000. § Helix Biomedix, 2001-4. § Ortho-McNeil Pharmaceuticals, 2001. §
Symyx, 2002. §
Inimex Pharmaceuticals Inc., 2003- §
Corus Pharma, 2004-5. §
Novartis, 2006-10. §
Cutanea, 2007. §
Polymedix, 2007. §
MicuRx, 2007-. §
Indel, 2007 §
Vertex 2009. Boards of Directors and Advisory Boards
§
Board of Directors, Micrologix Biotech Inc.,
§
Scientific Advisory Board, Chair, Micrologix Biotech
Inc., § Scientific Advisory Board, Infectious Diseases Biomedical Inc., Vancouver, 1992-95. § Board of Directors, Canadian Foundation for Infectious Diseases, 1994-96. § Board of Directors, Chair, David Elford Holding Company, 1995-97. § Board of Directors, Novadex Inc., B.C. 1995-96.
§
Scientific Advisory Board, Versicor, §
Advisory Board, Polydex Inc, New York, 1996-8. §
Scientific Advisory Board, Welichem, Vancouver, 1996-. §
Chair, Board of Directors, David Elford Forest
Management Ltd., 1997-02 §
President and Board of Directors, Inimex
Pharmaceuticals, §
Carded field hockey umpire since 2001. §
Medical Advisory Board, medbroadcast.com, 2002 §
Scientific Advisory Board, PolyBatics Inc, Palmerston
North, §
Chief Judge of instances of participation as a judge in local, regional and Canada-wide science Fairs and High Schools
Debating Tournaments. §
Director, REWH Consulting Inc, Vancouver 2008-. |
|
|
|
R.E.W.
Hancock Laboratory
Updated May 2010